Europe — EMA
Olmesartan/Amlodipine Ab (Olmesartan Medoxomil, Amlodipine)
Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipine Ab, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use.
Request sourcing
What is Olmesartan Medoxomil, Amlodipine?
Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipine Ab, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension, often in combination with a calcium‑channel blocker, and is intended for adult patients. GNH USA supplies Olmesartan/Amlodipine Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Olmesartan/Amlodipine Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Olmesartan Medoxomil, Amlodipine used for?
Olmesartan/Amlodipine Ab is indicated for hypertension management, targeting the renin‑angiotensin system and vascular smooth‑muscle tone.
- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension with high peripheral resistance: improves arterial compliance and flow. - Hypertension in patients requiring combination therapy: provides additive blood‑pressure control when monotherapy is insufficient.
What are the side effects of Olmesartan Medoxomil, Amlodipine?
Common Side Effects: - Peripheral edema edema - Headache - Dizziness - Flushing - Fatigue - Nausea
Serious or Rare Side Effects: - Angio‑immun - Hepatotoxic - Severe hypotension - Myocardial infarction - Acute kidney injury - Life‑threatening arrhythmias
What precautions apply to Olmesartan Medoxomil, Amlodipine?
Olmesartan/Amlodipine Ab should be used cautiously.
- Renal impairment: monitor renal function and electrolytes. - Hepatic impairment: dose adjustment may be needed. - Hyperkalemia: check serum potassium regularly.\n- Pregnancy - Cardiovascular - Store at t
